|
Groupa
|
Baseline
|
12 weeks
|
Between-group difference in change between baseline and 12 weeks
|
6 months
|
12 months
|
---|
| |
Mean(sig p-value) ± SD (No)
| |
Mean(sig p-value) ± SD (No)
|
---|
Weight (kg)
|
Inter
|
107.6 ± 15.0 (51)
|
101.6(<.001) ± 14.1 (44)
|
<.001
|
101.7(<.001) ± 13.2 (39)
|
102.0(<.001) ± 13.2 (38)
|
Comp
|
107.5 ± 19.5 (52)
|
106.2 ± 18.5 (42)
| | |
Weight (kg) (BOCF)
|
Inter
| |
103.3(<.001) ± 14.3 (51)
|
<.001
|
103.1(<.001) ± 13.2 (51)
|
104.8(<.001) ± 14.8 (51)
|
Comp
| |
108.0 ± 19.0 (52)
| | |
Weight loss from baseline (%)
|
Inter
|
n/a
|
4.6 ± 2.8 (44)
|
<.001
|
5.2 ± 4.2 (39)
|
3.5 ± 4.8 (38)
|
Comp
|
n/a
|
−0.6 ± 2.0 (42)
| | |
Weight loss from baseline (%) (BOCF)
|
Inter
| |
3.9 ± 3.0 (51)
|
<.001
|
4.0 ± 4.3 (51)
|
2.6 ± 4.4 (51)
|
Comp
| |
−0.5 ± 1.8 (52)
| | |
Waist circumference (cm)
|
Inter
|
117.2 ± 9.6 (51)
|
113.5(<.001) ± 9.9 (44)
|
<.001
|
110.5(<.001) ± 10.1 (34)
|
112.0(<.001) ± 9.0 (39)
|
Comp
|
116.5 ± 12.1 (52)
|
116.7(.014) ± 12.9 (41)
| | |
Systolic BP (mmHg)
|
Inter
|
142.7 ± 17.8 (51)
|
131.8(.003) ± 17.5 (24)
|
.013
|
134.2 ± 16.4 (30)
|
139.0 ± 19.3 (38)
|
Comp
|
140.1 ± 13.1 (49)
|
138.2 ± 19.1 (26)
| | |
Diastolic BP (mmHg)
|
Inter
|
89.8 ± 8.9 (51)
|
81.9(<.001) ± 8.4 (24)
| |
86.8 ± 11.1 (30)
|
85.2(.003) ± 9.6 (38)
|
Comp
|
91.3 ± 11.7 (49)
|
86.9 ± 12.7 (26)
| | |
Body fat (%)
|
Inter
|
30.8 ± 3.8 (42)
|
29.7 ± 3.7 (25)
|
<.001
|
29.7(.019) ± 4.2 (31)
|
29.4(.003) ± 4.0 (35)
|
Comp
|
30.7 ± 5.4 (48)
|
32.8(<.001) ± 5.6 (26)
| | |
- Note. Intervention group measured at baseline, 12 weeks, 6 months and 12 months; comparison group measured at baseline and 12 weeks only. Significant p-values (sig p-value) are reported for before-and-after within-group differences at 12 weeks, 6 months and 12 months, and between-group differences at 12 weeks. Sample sizes vary due to missing values. Sensitivity analyses conducted on weight outcomes using baseline observation carried forward (BOCF).
- aInter = intervention group; Comp = comparison group.